Abdominal versus vaginal surgery in the management of post hysterectomy vault prolapse: a randomised controlled study

ISRCTN ISRCTN49166896
DOI https://doi.org/10.1186/ISRCTN49166896
Protocol serial number N0236102638
Sponsor Department of Health
Funders St George's Healthcare NHS Trust (UK) No External Funding, NHS R&D Support Funding (UK)
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
18/10/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Stuart Stanton
Scientific

Gynaecology Department
Lanesborough Wing, Level 4
St George's Hospital
Blackshaw Road, Tooting
London
SW17 0QT
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleAbdominal versus vaginal surgery in the management of post hysterectomy vault prolapse: a randomised controlled study
Study objectivesTo determine the advantages and disadvantages of an abdominal or vaginal approach to correct vault prolapse/enterocele by conducting a prospective randomised controlled pilot trial comparing the abdominal sacrocolpopexy with mesh interposition and the vaginal bilateral iliococcygeal hitch
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedUrological and Genital Diseases: Prolapse
InterventionRandomised controlled trial
Intervention typeOther
Primary outcome measure(s)

Primary end point is the incidence of recurrence (Grade 2 prolapse) at 12 months post op.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/09/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target sample size at registration20
Key inclusion criteria20 in total, 10 controls
Key exclusion criteriaUterus insitu, severe chronic medical illnesses, clotting or bleeding disorders, asymptomatic prolapse, morbid obesity.
Date of first enrolment01/09/2001
Date of final enrolment30/09/2005

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Gynaecology Department
London
SW17 0QT
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

18/10/2017: No publications found, study status unverified.